Topics
Glioblastoma | Treatment | Radiotherapy | Radiosensitizers
Home > Publications > Topics > Glioblastoma > Treatment > Radiotherapy > Radiosensitizers
Pepper NB, Eich HT, Müther M,
Oertel M, Rehn S, Spille DC, Stummer W.
ALA-RDT
in GBM: protocol of the phase I/II dose escalation trial of
radiodynamic therapy with 5-Aminolevulinic acid in patients with
recurrent glioblastoma.
Radiat
Oncol. 2024 Jan
22;19(1):11. doi:
10.1186/s13014-024-02408-7. PMID:
38254201. Interventional
study protocol. ˍ
Liu M, Li T, Zhao M, Qian C, Wang R, Liu L, Xiao Y, Xiao H, Tang
X, Liu H.
Nanoradiosensitizers in
glioblastoma treatment: recent advances and future perspectives.
Nanomedicine
(Lond). 2024 Sep 23;19(26):2229-2249. doi:
10.1080/17435889.2024.2395238. PMID:
39311492. Review˰ ˍ
Mendez JS, Cohen AL, Eckenstein M, Jensen RL, Burt LM, Salzman KL,
Chamberlain M, Hsu HH, Hutchinson M, Iwamoto F, Ligon KL, Mrugala
MM, Pelayo M, Plotkin SR, Puduvalli VK, Raizer J, Reardon DA,
Sterba M, Walbert T, West BL, Wong ET, Zhang C, Colman H.
Phase
1b/2 study of orally administered pexidartinib in combination with
radiation therapy and temozolomide in patients with newly
diagnosed glioblastoma.
Neurooncol
Adv. 2024 Nov 22;6(1):vdae202. doi:
10.1093/noajnl/vdae202. PMID:
39734810. Interventional study. ˍ